Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,057 | -6,605 | -10,914 | -11,162 | -6,884 |
| Depreciation Amortization | 509 | 501 | 414 | 409 | 487 |
| Accounts receivable | -395 | 144 | 67 | -216 | 142 |
| Other Working Capital | 93 | 642 | -1,993 | -888 | 869 |
| Other Operating Activity | 6,486 | 778 | 2,591 | 3,695 | 761 |
| Operating Cash Flow | $-1,365 | $-4,540 | $-9,834 | $-8,162 | $-4,626 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -46 | -520 | -958 | -448 |
| Purchase Of Investment | N/A | N/A | -4,992 | -2,010 | N/A |
| Purchase Sale Intangibles | -96 | N/A | N/A | -6 | N/A |
| Other Investing Activity | -64 | 105 | -17 | 1,169 | -1,176 |
| Investing Cash Flow | $-64 | $59 | $-5,530 | $-1,799 | $-1,624 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 58 | N/A | 4,155 |
| Debt Repayment | -210 | -200 | -191 | -175 | -3,015 |
| Common Stock Issued | N/A | N/A | 375 | 2,089 | 1,293 |
| Dividend Paid | N/A | -163 | -411 | -34 | N/A |
| Other Financing Activity | 1,934 | 1,425 | 18,424 | -26 | 8,834 |
| Financing Cash Flow | $1,724 | $1,061 | $18,255 | $1,853 | $11,267 |
| Beginning Cash Position | 283 | 3,703 | 812 | 8,919 | 3,902 |
| End Cash Position | 578 | 283 | 3,703 | 812 | 8,919 |
| Net Cash Flow | $296 | $-3,420 | $2,891 | $-8,108 | $5,017 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,365 | -4,540 | -9,834 | -8,162 | -4,626 |
| Capital Expenditure | N/A | -46 | -520 | -958 | -448 |
| Free Cash Flow | -1,365 | -4,586 | -10,355 | -9,120 | -5,074 |